Breyer Capital

Company

Related News

Kos Fund Closes at $123M, ParcelBio Launches with $13M, Korsana Emerges with $175M

Jun 14, 2026

Three biotech companies announce significant funding: Korsana Biosciences secures $175 million for neurodegenerative therapies, Kos Biotechnology Partners closes a $123 million life sciences fund, and ParcelBio launches with $13 million to advance mRNA medicines.

2026 Healthcare Conferences Highlight AI Innovation and Cross-Border Care Trends

Jun 05, 2026

AI-driven innovation is reshaping healthcare, biotech, and life sciences, as highlighted at the 2026 Forbes Iconoclast Summit. The Global Medical Tourism & Insurance Summit will convene in Palm Beach, Florida, in May to address cross-border care solutions. The life sciences sector enters 2026 with regulatory acceleration and AI embedded across the industry.